Steven C Gilman - Net Worth and Insider Trading

Steven C Gilman Net Worth

The estimated net worth of Steven C Gilman is at least $1 Million dollars as of 2024-11-13. Steven C Gilman is the Director of Vericel Corp and owns about 11,000 shares of Vericel Corp (VCEL) stock worth over $614,900. Steven C Gilman is the Director of Momenta Pharmaceuticals Inc and owns about 7,796 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $409,134. Steven C Gilman is also the Director of Akebia Therapeutics Inc and owns about 43,430 shares of Akebia Therapeutics Inc (AKBA) stock worth over $84,906. Besides these, Steven C Gilman also holds Keryx Biopharmaceuticals Inc (KERX) , SCYNEXIS Inc (SCYX) , ContraFect Corp (CFRXQ) . Details can be seen in Steven C Gilman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven C Gilman has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steven C Gilman

To

Steven C Gilman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven C Gilman owns 6 companies in total, including Momenta Pharmaceuticals Inc (MNTA) , SCYNEXIS Inc (SCYX) , and Akebia Therapeutics Inc (AKBA) among others .

Click here to see the complete history of Steven C Gilman’s form 4 insider trades.

Insider Ownership Summary of Steven C Gilman

Ticker Comapny Transaction Date Type of Owner
MNTA Momenta Pharmaceuticals Inc 2020-10-01 director
SCYX SCYNEXIS Inc 2023-06-15 director
AKBA Akebia Therapeutics Inc 2022-06-03 director
LIMIT LIMIT 2017-07-25 director
LIMIT LIMIT 2024-10-16 director
LIMIT LIMIT 2018-12-12 director

Steven C Gilman Latest Holdings Summary

Steven C Gilman currently owns a total of 6 stocks. Among these stocks, Steven C Gilman owns 11,000 shares of Vericel Corp (VCEL) as of October 16, 2024, with a value of $614,900 and a weighting of 52.44%. Steven C Gilman owns 7,796 shares of Momenta Pharmaceuticals Inc (MNTA) as of August 5, 2020, with a value of $409,134 and a weighting of 34.89%. Steven C Gilman also owns 43,430 shares of Akebia Therapeutics Inc (AKBA) as of June 3, 2022, with a value of $84,906 and a weighting of 7.24%. The other 3 stocks Keryx Biopharmaceuticals Inc (KERX) , SCYNEXIS Inc (SCYX) , ContraFect Corp (CFRXQ) have a combined weighting of 5.42% among all his current holdings.

Latest Holdings of Steven C Gilman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VCEL Vericel Corp 2024-10-16 11,000 55.90 614,900
MNTA Momenta Pharmaceuticals Inc 2020-08-05 7,796 52.48 409,134
AKBA Akebia Therapeutics Inc 2022-06-03 43,430 1.96 84,906
KERX Keryx Biopharmaceuticals Inc 2018-06-11 17,333 3.36 58,239
SCYX SCYNEXIS Inc 2020-12-21 4,000 1.34 5,360
CFRXQ ContraFect Corp 2017-07-25 26 0.00 0

Holding Weightings of Steven C Gilman


Steven C Gilman Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven C Gilman has made a total of 8 transactions in Vericel Corp (VCEL) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Vericel Corp is the sale of 5,833 shares on October 16, 2024, which brought Steven C Gilman around $241,253.

According to the SEC Form 4 filings, Steven C Gilman has made a total of 3 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 13,000 shares on August 5, 2020, which brought Steven C Gilman around $425,750.

According to the SEC Form 4 filings, Steven C Gilman has made a total of 4 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 4,567 shares on June 3, 2022, which brought Steven C Gilman around $1,644.

More details on Steven C Gilman's insider transactions can be found in the Insider Trading History of Steven C Gilman table.

Insider Trading History of Steven C Gilman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven C Gilman Trading Performance

GuruFocus tracks the stock performance after each of Steven C Gilman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven C Gilman is 54.51%. GuruFocus also compares Steven C Gilman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven C Gilman within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven C Gilman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven C Gilman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 23.22 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 21.56 LIMIT LIMIT LIMIT LIMIT LIMIT

Steven C Gilman Ownership Network

Ownership Network List of Steven C Gilman

No Data

Ownership Network Relation of Steven C Gilman

Insider Network Chart

Steven C Gilman Owned Company Details

What does Momenta Pharmaceuticals Inc do?

Who are the key executives at Momenta Pharmaceuticals Inc?

Steven C Gilman is the director of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief Legal Officer Alejandra Carvajal , Chief Scientific Officer Anthony M. Manning , and SVP & Chief Medical Officer Santiago Arroyo .

Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Momenta Pharmaceuticals Inc Insider Transactions

No Available Data

Steven C Gilman Mailing Address

Above is the net worth, insider trading, and ownership report for Steven C Gilman. You might contact Steven C Gilman via mailing address: 110 Hartwell Avenue, Lexington Ma 02421.